Related Experiment Video
Updated: May 20, 2026

06:00
Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
Published on: January 26, 2024
Nanomolar electrochemiluminescence via smartphone: Image encoding matters.
Rajendra Kumar Reddy Gajjala1, Mikel Díaz2, Peio Lopez-Iturri2
1BCMaterials, Basque Center for Materials, Applications and Nanostructures. UPV/EHU Parque Científico, Leioa, Bizkaia, E-48940, Spain.
Biosensors & Bioelectronics
|May 18, 2026
Summary
This study introduces a smartphone-based electrochemiluminescence (ECL) detection method. By optimizing image acquisition and processing, it achieves nanomolar detection limits for decentralized diagnostics.
Area of Science:
- Analytical Chemistry
- Biomedical Engineering
- Imaging Science
Background:
- Smartphone electrochemiluminescence (ECL) offers potential for decentralized diagnostics.
- Existing methods are limited by unaddressed error sources: acquisition parameters, gamma encoding, and JPEG compression.
- These limitations hinder sensitivity and reliable quantification in smartphone-based ECL detection.
Purpose of the Study:
- To develop and validate a quantitative framework for smartphone ECL imaging.
- To address key error sources limiting sensitivity in smartphone-based ECL detection.
- To enable reliable, on-device, decentralized diagnostics using mobile devices.
Main Methods:
- Optimized image acquisition using long-exposure RAW images under fixed conditions.
- Developed a processing pipeline (ECLiCare app) involving full-histogram integration and inverse sRGB transfer function.
- Utilized screen-printed glassy carbon electrodes with a ruthenium(II)/tripropylamine system for ECL generation.
Main Results:
- Achieved nanomolar detection limits (16 nM) and quantification limits (53 nM) in solution, surpassing previous smartphone-based systems.
- Demonstrated the critical importance of lossless image formats, as JPEG compression yields misleadingly low detection limits.
- Validated the workflow on a sandwich immunoassay, achieving a detection limit of 2.31 μg/mL for epidermal growth factor receptor.
Conclusions:
- A comprehensive workflow, ECLiCare, enables sensitive smartphone-based ECL detection by addressing critical error sources.
- The developed method provides a reliable, on-device quantitative framework for field and point-of-care deployment.
- This advancement paves the way for accessible, decentralized diagnostic tools using ubiquitous smartphone technology.

